News Conference News NY Valves 2025 Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL Yael L. Maxwell July 01, 2025
News Conference News NY Valves 2025 Global Burden of Degenerative Mitral Valve Disease Continues to Rise Todd Neale June 30, 2025
News Conference News NY Valves 2025 Good Outcomes, Little Hospital Experience: Pascal TEER in Real World Yael L. Maxwell June 30, 2025
News Conference News NY Valves 2025 Failure of ‘Jailed’ CIED Leads Not Uncommon After TTVR: TRIPLACE Todd Neale June 27, 2025
News Daily News ‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use Yael L. Maxwell June 18, 2025
News Daily News Tendyne Approved in US for High-risk Patients With Mitral Valve Disease Michael O'Riordan May 28, 2025
News Conference News EuroPCR 2025 Myval Noninferior to Other THVs at 1 Year, but Questions Persist L.A. McKeown May 21, 2025
News Conference News SCAI 2025 BATMAN Signals New Way to Prevent LVOT Obstruction in High-Risk TMVR Patients L.A. McKeown May 07, 2025
News Conference News HRS 2025 Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe Todd Neale April 28, 2025
News Daily News LuX-Valve TTVR Device Provides Favorable 1-Year Results Yael L. Maxwell April 24, 2025
News Daily News COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year Todd Neale April 11, 2025
News Conference News ACC 2025 By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE Michael O'Riordan March 31, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Conference News ACC 2025 More ALIGN-AR Data Bolster Potential for a Dedicated AR Device Yael L. Maxwell March 30, 2025
News Opinion Editor's Corner ACC 2025 What’s Going to Be Hot at ACC 2025? Michael O'Riordan March 26, 2025